BIO, PhRMA Jointly Launch PDUFA Tracking Database

In an effort to streamline future user fee reauthorization negotiations and track the progress of new molecular entity review goals set under PDUFA V, PhRMA and the Biotechnology Industry Organization have created a “PDUFA tracking database” to collect real-time information from their members about FDA-industry interactions throughout the review process.
Washington Drug Letter